The Business Research Company’s report on the Pharmaceutical Stability And Storage Services Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the pharmaceutical stability and storage services industry?
The increasing number of novel drug approvals is expected to propel the growth of the pharmaceutical stability and storage services market going forward. A novel drug refers to a pharmaceutical compound that is newly developed and has never been previously approved for use or marketed. The increasing number of novel drug approvals is due to advancements in biotechnology, enabling the discovery of new compounds and improved regulatory processes that facilitate faster, more efficient drug development. The rise in novel drug approvals drives demand for pharmaceutical stability and storage services, ensuring optimal conditions, compliance, and extended shelf-life management. For instance, in October 2023, according to the U.S. Food and Drug Administration (FDA), a U.S.-based federal agency responsible for protecting public health, in 2022, the FDA approved 37 novel drugs, followed by 50 in 2024, advancing treatments across cancer, rare diseases, neurology, infections, and conditions like schizophrenia, pain, and Alzheimer’s. Therefore, the increasing number of novel drug approvals drive the growth of the pharmaceutical stability and storage services market.
Access Your Free Sample of the Global Pharmaceutical Stability And Storage Services Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=23473&type=smp
What is the estimated market size of the pharmaceutical stability and storage services sector by 2029, based on current forecasts?
The pharmaceutical stability and storage services market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the increasing demand for biologics, increasing prevalence of chronic diseases, growth in drug development, increasing complexity of drug formulations, and growing research and development in pharmaceuticals.
The pharmaceutical stability and storage services market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rising personalized medicine, increasing cold chain logistics, expanding biopharma pipelines, rising biologic drug approvals, and growing demand for stability testing. Major trends in the forecast period include technological advancements, advancements in cryogenic storage technologies, development in digital monitoring technologies, development of innovative packaging technologies, and advanced temperature-controlled storage systems.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=23473&type=smp
Who are the top players in the pharmaceutical stability and storage services market?
Major companies operating in the pharmaceutical stability and storage services market are Cencora Inc, SGS S.A., Eurofins Scientific SE, Catalent Inc, Charles River Laboratories, Intertek Group plc, Element Materials Technology Inc, Alloga UK Ltd., ALS Limited, Pharmaceutical Contract Industries Pharma Services., Almac Group, Alcami Corporation, BioLife Solutions Inc., Auriga Research Private Limited, Reading Scientific Services Ltd., Lucideon Limited, Q Laboratories Inc, PD Partners, Precision Stability Storage, Roylance Stability Storage Limited
What are the major trends in the pharmaceutical stability and storage services market?
Major companies operating in the pharmaceutical stability and storage services market are focusing on developing technologically advanced solutions, such as cryogenic storage suites, to enhance the preservation of temperature-sensitive pharmaceutical products. Cryogenic storage suites are specialized storage facilities that maintain extremely low temperatures, typically below -150°C, to preserve temperature-sensitive biological and pharmaceutical materials such as cell therapies, vaccines, and biologics. For instance, in December 2024, Astoriom, a UK-based stability and biospecimen storage industry, launched a cryogenic storage suite at its Tramore facility in County Waterford, Ireland, marking a significant expansion in its capabilities for biological sample storage. This state-of-the-art suite is designed to meet the increasing demand for safe, long-term preservation of biological materials, ensuring their viability over extended periods. This storage features precise temperature control down to -196°C, vast storage capacity, ISO 9001 certification for regulatory compliance, and advanced security measures, including access controls and monitoring systems.
Which geography holds the highest pharmaceutical stability and storage services market share?
North America was the largest region in the pharmaceutical stability and storage services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical stability and storage services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
How do different segments contribute to the overall expansion of the pharmaceutical stability and storage services market?
The pharmaceutical stability and storage services market covered in this report is segmented –
1) By Service: Stability, Storage
2) By Product Type: Tablets, Capsules, Injectable Solutions, Oral Suspensions, Combination Products, Other Product Types
3) By Molecule: Small Molecule, Large Molecule
4) By Mode: In-House, Outsourcing
5) By End User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Other End Users
Subsegments:
1) Stability Services: Long-Term Stability Studies, Accelerated Stability Studies, Intermediate Stability Studies, Photostability Testing, Forced Degradation Studies
2) Storage Services: Ambient Storage, Refrigerated Storage (2°C to 8°C), Frozen Storage (-20°C to -80°C), Cryogenic Storage (-150°C to -196°C), Controlled Drug Substance And Product Storage
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23473
What defines the structure and scope of the pharmaceutical stability and storage services market?
Pharmaceutical stability and storage services refer to specialized services to ensure that pharmaceutical products (such as drugs, medications, and vaccines) maintain their quality, efficacy, and safety over time. These services include controlled environments for storing drugs, conducting stability studies to monitor chemical, physical, and microbiological changes, and ensuring compliance with regulatory standards.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
